RPB0352

Pathogen Description

Target Pathogen Pathogen Name NCBI Taxonomy ID Order Family Genus Species Pathogen type
Nipah virus Nipah henipavirus 121791 Mononegavirales Paramyxoviridae Henipavirus Nipah virus Virus

Primer Description

Primer Name Sequence(5'-3') Length(bp) Primer Final Concentration(μM) GC Content(%) Predicted Melting Temperature(℃) Molecular Weight(g/moles) Positions in GenBank accession number
F4 CAAATAGACTGGGACTAAGTTCAGATCAAG 30 10 μM 40 56.36 9272.12 \
R4 ATGAAATACTCATCTCCCTTTTGAAGGTAA 30 10 μM 33.33 55.04 9164.05 \

Gene Description

Target Gene GenBank ID
N gene KY425646.1

Assay Description

Application Assay Primer Designing Software Reaction Time(min) Assay Temperature(℃) Readout System(s) Limit of Detection(LoD) Sensitivity(%) Specificity(%)
rapid,sennsitive, specific and instrument-free testing simultaneously would be more effective in preventing and controlling NiV. RAA-CRISPR\Cas12a-FQ primer-BLAST 20 min 37 °C CRISPR\Cas12a-FQ 10 copies per μL \ \

Publication Description

Year of Publication Title Author(s) Journal PMID DOI
2024 Novel methods for the rapid and sensitive detection of Nipah virus based on a CRISPR\Cas12a system Xi Yang,Kexin Xu,Siying Li,Jiangnian Zhang,Yinli Xie,Yongliang Lou,Xingxing Xiao Analyst 38497408 10.1039/d4an00027g

Novel methods for the rapid and sensitive detection of Nipah virus based on a CRISPR\Cas12a system

Author(s):

Xi Yang,Kexin Xu,Siying Li,Jiangnian Zhang,Yinli Xie,Yongliang Lou,Xingxing Xiao

Journal:

Analyst

Year:

2024

Abstract:

Nipah virus (NiV), a bat-borne zoonotic viral pathogen with high infectivity and lethality to humans, has caused severe outbreaks in several countries of Asia during the past two decades. Because of the worldwide distribution of the NiV natural reservoir, fruit bats, and lack of effective treatments or vaccines for NiV, routine surveillance and early detection are the key measures for containing NiV outbreaks and reducing its influence. In this study, we developed two rapid, sensitive and easy-to-conduct methods, RAA-CRISPR/Cas12a-FQ and RAA-CRISPR/Cas12a-FB, for NiV detection based on a recombinase-aided amplification (RAA) assay and a CRISPR/Cas12a system by utilizing dual-labeled fluorophore-quencher or fluorophore-biotin ssDNA probes. These two methods can be completed in 45 min and 55 min and achieve a limit of detection of 10 copies per μL and 100 copies per μL of NiV N DNA, respectively. In addition, they do not cross-react with nontarget nucleic acids extracted from the pathogens causing similar symptoms to NiV, showing high specificity for NiV N DNA detection. Meanwhile, they show satisfactory performance in the detection of spiked samples from pigs and humans. Collectively, the RAA-CRISPR/Cas12a-FQ and RAA-CRISPR/Cas12a-FB methods developed by us would be promising candidates for the early detection and routine surveillance of NiV in resource-poor areas and outdoors.